FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to hepatology, and describes a method for examining the liver detoxification function state. The method involves measuring fasting blood AWM (average weigh molecule), ALT (alanine aminotransferase) and AST (aspartate aminotransferase), measuring the same values the night before at bedtime, as well as measuring a circulating blood volume and a packed cell volume in the morning and in the evening followed by determining a coefficient of the liver detoxification function state; and if observing the derived coefficient K≤0.6, the liver detoxification function state is considered to be satisfactory, while the coefficient K>0.6 shows the depressed liver detoxification function.
EFFECT: method provides the more reliable assessment of the liver detoxification function state.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR STUDYING PROTEIN SYNTHESIS LIVER FUNCTION | 2015 |
|
RU2597765C1 |
| METHOD FOR STUDYING THE METABOLISM OF BILIRUBIN | 2021 |
|
RU2757156C1 |
| METHOD FOR STUDY OF CHOLESTEROL METABOLISM | 2021 |
|
RU2757637C1 |
| METHOD FOR ASSESSING THE FUNCTIONAL STATE OF THE LIVER OF CATTLE | 2021 |
|
RU2773414C1 |
| METHOD FOR LIPOPROTEINS SYNTHESIS RESEARCH | 2015 |
|
RU2620553C1 |
| AGENT "EXTRAHOLM" FOR SUGAR CONTROL IN PATIENTS SUFFERING FROM DIABETES COMPLICATED BY HEPATOPATHY AND BILE PASSAGES DISORDERS | 2007 |
|
RU2360695C1 |
| METHOD OF ASSESSING THE SEVERITY OF LIVER DYSFUNCTION IN CATTLE | 2022 |
|
RU2803003C1 |
| METHOD FOR TREATING THE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AT APPLYING THE CRYOHEPARINOPRECIPITATION | 2000 |
|
RU2188012C2 |
| WAY OF LOW-FLOW ULTRAHEMOFILTRATION AT TREATMENT OF PATIENTS WITH PANCREATONECROSIS | 2008 |
|
RU2363498C1 |
| AGENT FOR ALCOHOLIC TOXICOSIS | 2011 |
|
RU2493867C2 |
